Table 4 Outcomes of pregnancies with... | American Society of Hematology

Table 4

Outcomes of pregnancies with paternal exposure to rituximab

Country	Indication	Report type	Narrative	Pregnancy Outcome
United Kingdom	TTP	Study	No information provided	SAB
United States	RA	Study	No information provided	Healthy female, 33 wk
United States	Unknown	Spontaneous	No information provided	SAB
United States	Unknown	Spontaneous	No information Provided	SAB
United States	Unknown	Spontaneous	No information Provided	SAB
United States	MS	Study	Patient's partner became pregnant 4 mo after patient received rituximab	SAB
Israel	RA	Study	Patient's partner was in the first trimester of pregnancy when patient received rituximab	SAB
Brazil	Lymphoma	Spontaneous	Patient's partner became pregnant 2 mo after patient received rituximab	Healthy female
Venezuela	Lymphoma	Study	Patient's partner became pregnant 1 mo after patient received rituximab	Healthy twins, 37 wk
Australia	TTP	Spontaneous	Patient's partner became pregnant 7 mo after patient received rituximab	Healthy male
United Kingdom	Lymphoma	Spontaneous	Patient's partner became pregnant 7 mo after patient received rituximab	Healthy male
Canada	RA	Study	Patient's partner became pregnant 5 mo after patient received rituximab	Healthy female, 39 wk
Netherlands	TTP	Study	Patient's partner became pregnant within 1 y after patient received rituximab	Healthy male
France	RA	Spontaneous	Patient's partner became pregnant within 1 y after patient received rituximab	Healthy male, 37 wk
Australia	Lymphoma	Study	Patient's partner became pregnant 3 months after patient received rituximab	Ongoing
United States	malignancy	Spontaneous	Patient's partner became pregnant 2 wk after patient received rituximab	Ongoing

Country	Indication	Report type	Narrative	Pregnancy Outcome
United Kingdom	TTP	Study	No information provided	SAB
United States	RA	Study	No information provided	Healthy female, 33 wk
United States	Unknown	Spontaneous	No information provided	SAB
United States	Unknown	Spontaneous	No information Provided	SAB
United States	Unknown	Spontaneous	No information Provided	SAB
United States	MS	Study	Patient's partner became pregnant 4 mo after patient received rituximab	SAB
Israel	RA	Study	Patient's partner was in the first trimester of pregnancy when patient received rituximab	SAB
Brazil	Lymphoma	Spontaneous	Patient's partner became pregnant 2 mo after patient received rituximab	Healthy female
Venezuela	Lymphoma	Study	Patient's partner became pregnant 1 mo after patient received rituximab	Healthy twins, 37 wk
Australia	TTP	Spontaneous	Patient's partner became pregnant 7 mo after patient received rituximab	Healthy male
United Kingdom	Lymphoma	Spontaneous	Patient's partner became pregnant 7 mo after patient received rituximab	Healthy male
Canada	RA	Study	Patient's partner became pregnant 5 mo after patient received rituximab	Healthy female, 39 wk
Netherlands	TTP	Study	Patient's partner became pregnant within 1 y after patient received rituximab	Healthy male
France	RA	Spontaneous	Patient's partner became pregnant within 1 y after patient received rituximab	Healthy male, 37 wk
Australia	Lymphoma	Study	Patient's partner became pregnant 3 months after patient received rituximab	Ongoing
United States	malignancy	Spontaneous	Patient's partner became pregnant 2 wk after patient received rituximab	Ongoing